SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* WHITEHEAD ROBERT S (Last) (First) (Middle) C/O ISLEWORTH HEALTHCARE ACQUISITION COR 970 LAKE CARILLON, FEATHER SOUND, STE 30 (Street) ST. PETERSBURG FL 33716 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol Isleworth Healthcare Acquisition Corp. [ ISLEU ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer
	3. Date of Earliest Transaction (Month/Day/Year) 03/01/2021
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Private Warrants to purchase common stock	$11.5	03/01/2021		P		4,480,000(1)		(2)	(3)	Common stock	4,480,000	$1	4,480,000	I	By Isleworth Healthcare Sponsor I, LLC(4)
Private Warrants to purchase common stock	$11.5	03/02/2021		P		432,000(1)		(2)	(3)	Common stock	432,000	$1	4,912,000	I	By Isleworth Healthcare Sponsor I, LLC(4)

1. Name and Address of Reporting Person* WHITEHEAD ROBERT S (Last) (First) (Middle) C/O ISLEWORTH HEALTHCARE ACQUISITION COR 970 LAKE CARILLON, FEATHER SOUND, STE 30 (Street) ST. PETERSBURG FL 33716 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer X Director 10% Owner X Officer (give title below) Other (specify below) Chief Executive Officer

1. Name and Address of Reporting Person* Isleworth Healthcare Sponsor I LLC (Last) (First) (Middle) 970 LAKE CARILLON DRIVE, FEATHER SOUND SUITE 300 (Street) ST. PETERSBURG FL 33716 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

1. Isleworth Healthcare Sponsor I, LLC ("Sponsor") purchased 4,480,000 warrants and 432,000 warrants on March 1, 2021 and March 2, 2021, respectively, as described in the issuer's registration statement on Form S-1 (File No. 333-252308), in a private placement of warrants at a price of $1.00 per private placement warrant. Each whole private placement warrant is exercisable to purchase one share of common stock at a price of $11.50 per share.

2. The warrants become exercisable on the later of (i) 30 days after the completion of the registrant's initial business combination and (ii) 12 months from the closing of the registrant's initial public offering.

3. The warrants expire five years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the Form S-1 (File No. 333-252308).

4. The warrants are held by Sponsor. Robert Whitehead is the sole manager of the Sponsor. Mr. Whitehead disclaims beneficial ownership of the securities held by the Sponsor except to the extent of his pecuniary interest therein.

Remarks:

	/s/ Robert Whitehead	03/03/2021
	/s/ Isleworth Healthcare Sponsor I, LLC, by Robert Whitehead as Manager	03/03/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.